Skip to content

Gastric Layering Study

A Study on the Effect of Gastric Layering and Emptying Induced by a Food Emulsion

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01565057
Enrollment
10
Registered
2012-03-28
Start date
2011-08-31
Completion date
2012-05-31
Last updated
2012-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Keywords

emulsion, emptying, protein, layering

Brief summary

This comparative study is designed to compare the gastric layering and rates of emptying and by inference rates of digestion of two food emulsions. Two types of dairy based foods will be used, one which will sediment in the stomach and one that will not. On each of two study days, a total of 9 post drink MRI scans will be taken to assess gastric layering and emptying. Cannulation will allow blood samples to be taken periodically for subsequent analysis for the presence of specific digestion related hormones. A total volume of 36 ml of blood will be removed and volunteers will also be asked to complete a questionnaire at predetermined times to assess feelings of satiation.

Interventions

OTHERsedimenting meal

The active system quickly forms a sedimenting layer of small particles that contain most of the caloric content of the system. This system is made by adding finely grated cheese (particle size 0.5-2 mm) to yoghurt and consumption is followed by drinking 327 ml water.

Sponsors

Norfolk and Norwich University Hospitals NHS Foundation Trust
CollaboratorOTHER
Top Institute Food and Nutrition
CollaboratorOTHER
Quadram Institute Bioscience
Lead SponsorOTHER

Study design

Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Male (hormonal status of women would introduce more variation within small group) * Age 20-50y * BMI 19-30 * Apparently healthy * Normally eat lunch * Willing to eat the finely grated cheese meal * Provide written informed consent

Exclusion criteria

* Individuals with an intolerance or allergy to any of the constituents of the test meal * Smokers or smoked within the last year (smoking affects satiety/hunger) * Diagnosed with any long term illness requiring active treatment e.g. diabetes, cancer, cardiovascular disease * Have had surgery on the stomach or intestine or suffered from gastrointestinal disease, whether diagnosed or self reported * Regular (more than once in 10 days) use of antacids, laxatives * Any problems with swallowing * Take prescription medication for digestive or gastrointestinal conditions. * Volunteers taking part in another study (other than a questionnaire based study). * Blood pressure greater than 160/100 or less than 90/50 or 95/55 if symptomatic. * Individuals with special dietary requirements (eg vegetarians) * If attended a study during the previous four months where combined blood sampling from previous study and present study would exceed 470mL. * If any of the clinical screening results are indicative of a health problem which would affect the volunteers well-being or which would affect the study data. * Refusal to give permission to inform GP of participation in study * Recent unexplained weight gain or loss * History of back problems or any other condition which limit ability to repeatedly sit up and lie down * Hiatus Hernia * MRI scanning specific

Design outcomes

Primary

MeasureTime frameDescription
Gastric emptying rates3 hoursThe primary objective is to measure gastric emptying rates and layering patterns as a function of time in healthy volunteers using two different meals, one which sediments gastric digestion and one in which it does not.

Secondary

MeasureTime frameDescription
Fullness and satiety from visual analogue scores3.5 hoursTo correlate gastric emptying rates with satiety responses after the meal
levels of CCK in the blood3.5 hoursTo correlate gastric emptying rates with levels of the GI hormone CCK in blood

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026